We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Test Determines Genetic Resistance to HIV

By HospiMedica staff writers
Posted on 07 Jul 2006
A test has been developed that determines if a person is a fast, neutral, or slow progressor to AIDS after human immunodeficiency virus (HIV) infection. More...


The results of the test help individuals infected with HIV know how quickly the virus is likely to cause disease, enabling physicians to decide how aggressive the therapy needs to be for each patient.

The test was developed by Independent Forensics (Jersey City, NJ, USA). It measures the genetics of CCR5 receptors on T-cells and uses a simple buccal swab collection procedure, which can be easily carried out at home. Test results are available in three weeks. CCR5 is the primary HIV receptor in T-cells, and people contain varying amounts of this receptor according to their genetic make-up. The fewer available CCR5 receptors people have, the more likely it is that they will demonstrate a slow progression to AIDS when infected with HIV-1.

"We believe the CCR5 halotype test is one of the most important things an individual with HIV can do to help in their treatment. It is part of our philosophy to 'Know Thyself', knowing your own genetic makeup will help everyone make informed and healthy life decisions,” explained Jack Keehma, CEO of Independent Forensics.

Independent Forensics' services include paternity, immigration, Codis data basing, casework, expert witness testimony, and product development for the forensic community. The company's products include SampleTrak software and rapid-stain identification tests for saliva and semen.



Related Links:
Independent Forensics

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
X-Ray Meter
Cobia SENSE
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.